1.	Celecoxib in Treating Patients With Bladder Cancer Phase: Phase III, Phase II Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00869, ID99-368, N01CN85186, MDA-ID-99368, NCI-P00-0165, SC-NQ4-99-02-006, NCT00006124
2.	Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses Phase: Phase III, Phase II Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069099, UAB-9833, UAB-NQ401A4009, UAB-NQ49902009, NCI-P00-0161, NCI-P01-0197, NCT00027976
3.	Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis Phase: Phase III, Phase II Type: Prevention Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: RUN 2008-4198, ABR nr.: NL23569.091.08, CMO: 2008/148, EudraCT: 2008-003696-43, NCT00808743
4.	Phase III Randomized Study of Celecoxib for Prevention of New Sporadic Adenomatous Colorectal Polyps in Patients Who Have Undergone Polypectomy Phase: Phase III Type: Prevention Status: Closed Age: 30 and over Sponsor: NCI Protocol IDs: BWH-NO1-CN-95015, NYH-CMC-0298-108, SC-IQ4-99-02-005, STRANG-98-008, NCI-P00-0141, NCT00005094
5.	Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-40015, NCT00064181
6.	Phase III Randomized Study of Adjuvant Celecoxib With Fluorouracil and Leucovorin Calcium in Patients With Curatively Resected Stage III Adenocarcinoma of the Colon. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-40023, PETACC-5, NCT00085163
7.	Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SLCSG0501, NCT00300729
8.	Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) Phase: Phase III Type: Prevention Status: Completed Age: 30 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EQ4-00-02-018, A3191107, NCT00141193
9.	Phase I/II Randomized Study of Celecoxib for Hereditary Nonpolyposis Colorectal Cancer Patients and Gene Carriers (Summary Last Modified 02/2001) Phase: Phase II, Phase I Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0087
10.	Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 85 Sponsor: NCI, Other Protocol IDs: CDR0000068849, RTOG-C-0128, NCT00023660
11.	Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069476, RTOG-0213, NCT00046839
12.	Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 3c-03-19, NCT00159484
13.	A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NP01/07/03, NCT00212108
14.	Celebrex With Preoperative Chemoradiation - Rectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 02-0130-C, Ontario Cancer ResearchNetwork, NCT00188565
15.	Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000490047, CHUV-CEPO-161-05, EU-20627, NCT00357617
16.	Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 0405-2006, NCT00400374
17.	Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor Phase: Phase II, Phase I Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 0596-2004, NCT00314262
18.	Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 19 and over Sponsor: Other Protocol IDs: F020703003, Link No: 000276825, NCT00581971
19.	Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 02I6, NCT00057980
20.	Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 01L2, PHARMACIA-NU-01L2, NCT00073866
21.	Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00730, 2009-0804, N01CN35159, NCT01021215
22.	Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus Phase: Phase II Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: JHOC-J9932, CDR0000067917, P30CA006973, JHOC-J9932, JHOC-99061108, NCI-P00-0145, NCT00005878
23.	Phase II Study of Celecoxib and Trastuzumab (Herceptin) in Women With HER2/neu-Overexpressing Metastatic Breast Cancer That is Refractory to Prior Trastuzumab. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-00078, NCI-G00-1869, NCT00006381
24.	Celecoxib in Treating Patients With Precancerous Lesions of the Mouth Phase: Phase II Type: Prevention Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: 00-111, MSKCC-00111, NCI-G01-1930, NCT00014404
25.	Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers Phase: Phase II Type: Prevention Status: Completed Age: Over 45 Sponsor: NCI, Other Protocol IDs: CDR0000068727, P30CA016042, UCLA-0012067, NCI-G01-1966, NCT00020878